Immune modulation by danazol in autoimmune thrombocytopenia
- 1 March 1987
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 42 (3), 281-287
- https://doi.org/10.1016/0090-1229(87)90016-x
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Differences in T cell subsets between men and women with idiopathic thrombocytopenic purpuraBlood, 1985
- Danazol Therapy for Autoimmune Hemolytic AnemiaAnnals of Internal Medicine, 1985
- Danazol for the Treatment of Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1983
- DanazolAnnals of Internal Medicine, 1982
- Abnormal autologous mixed lymphocyte reaction in autoimmune thrombocytopenic purpuraBlood, 1982
- Impaired lymphocyte transformation and capping in autoimmune thrombocytopenic purpuraBlood, 1979
- Treatment of Idiopathic Thrombocytopenic Purpura (ITP)Annual Review of Medicine, 1977
- Stimulation of Nonimmunized Lymphocytes by Platelet-Antibody Complexes in Idiopathic Thrombocytopenic PurpuraNew England Journal of Medicine, 1973
- CELLULAR IMMUNITY TO AUTOLOGOUS PLATELETS AND SERUM-BLOCKING FACTORS IN IDIOPATHIC THROMBOCYTOPENIC PURPURAThe Lancet, 1972
- SIMILARITIES BETWEEN KNOWN ANTIPLATELET ANTIBODIES AND THE FACTOR RESPONSIBLE FOR THROMBOCYTOPENIA IN IDIOPATHIC PURPURA. PHYSIOLOGIC, SEROLOGIC AND ISOTOPIC STUDIESAnnals of the New York Academy of Sciences, 1965